Oks Biotech Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 20 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 216.41%
- Profit Growth 208.47%
- Ebitda 86.64%
- Net Worth 3.15%
- Total Assets 1.84%
About Oks Biotech
Oks Biotech Private Limited (OBPL) is a Private Limited Indian Non-Government Company incorporated in India on 16 December 2004 and has a history of 20 years and one month. Its registered office is in Delhi, India.
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Nitin Talwar, Nizamuddin Khan, and Seher Nayeem serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U74999DL2004PTC131332
- Company No.
131332
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Dec 2004
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Oks Biotech?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Seher Nayeem  | Director | 31-Aug-2021 | Current |
Nitin Talwar  | Director | 11-Oct-2023 | Current |
| Nizamuddin Khan | Director | 31-Mar-2023 | Current |
Financial Performance of Oks Biotech.
Oks Biotech Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 216.41% increase. The company also saw a substantial improvement in profitability, with a 208.47% increase in profit. The company's net worth moved up by a moderate rise of 3.15%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Oks Biotech?
In 2020, Oks Biotech had a promoter holding of 99.99% and a public holding of 0.01%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
V Publishing Solutions Private LimitedNizamuddin Khan is a mutual person
Exactus Corporation Private LimitedNizamuddin Khan and Seher Nayeem are mutual person
Oks Group International Private LimitedNitin Talwar, Nizamuddin Khan and 1 more are mutual person
- Oks Education Private Limited
Nitin Talwar, Nizamuddin Khan and 1 more are mutual person
- Oks Prepress Services Private Limited
Nizamuddin Khan is a mutual person
Infoark It Solutions LlpNitin Talwar is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Oks Biotech?
Unlock and access historical data on people associated with Oks Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Oks Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Oks Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
